FIELD: chemistry.
SUBSTANCE: present invention relates to mixtures containing: i) at least one lipid and/or at least one oil; and ii) alkylammonium EDTA salt; where the mixture has a water content in the range from 0 to 1.0 wt.%. The invention additionally relates to preliminary filled devices for the administration of compositions, to the use of alkylammonium EDTA salt for reducing the destruction of lipid components and/or any active agent contained in the preliminary composition, and to alkylammonium EDTA salts, such as described in the present document.
EFFECT: obtaining mixtures and compositions containing alkylammonium EDTA salt.
13 cl, 18 dwg, 19 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE ANALOG OF ACYLATED OXYNTOMODULIN | 2018 |
|
RU2752787C1 |
| PEGILATED BIOLOGICALLY ACTIVE PEPTIDES AND THEIR APPLICATION | 2017 |
|
RU2748576C2 |
| LONG-ACTING DOUBLE AGONIST OF GLUCAGON-LIKE PEPTIDE-1 AND GLUCAGON RECEPTORS | 2021 |
|
RU2799327C1 |
| NOVEL OXYNTOMODULIN DERIVATIVES AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM FOR TREATING OBESITY | 2012 |
|
RU2739209C2 |
| HIGH-PENETRATION PRODRUG COMPOSITIONS BASED ON PEPTIDES AND PEPTIDE-RELATED COMPOUNDS | 2010 |
|
RU2767051C2 |
| INSULIN ANALOGUES | 2017 |
|
RU2769476C2 |
| PEPTIDES AND PEPTIDOMIMETICS FOR COMBINED USE AND TREATMENT IN A SUBPOPULATION OF PATIENTS WITH CANCER DISEASES | 2014 |
|
RU2732440C2 |
| METHOD FOR TARGETED IMPACT ON EXOSOMES | 2018 |
|
RU2781640C2 |
| GIP AGONIST COMPOUNDS AND METHODS | 2015 |
|
RU2716985C2 |
| PEPTIDES AND PEPTIDOMIMETICS IN COMBINATION WITH CONTROL POINT INHIBITING AGENTS FOR TREATING CANCER | 2016 |
|
RU2739201C2 |
